To Claim Award: Ctrl-P, cut along border, tape to plaque (note: plaque not included). M&A of the Year: Amgen/Onyx Congratulations...

It's time for the IN VIVO Blog's Sixth Annual Deal of the Year! competition. This year we're once again presenting awards in th...

GlaxoSmithKline is following some of its big pharma peers to key innovation hubs in the U.S. by opening satellite R&D centers in ...

More options are always better, right? Obviously, that’s a “yes” when it comes to building our dream Tesla Model S. But big biopharma is ...

Skeptical kitten wants to see what comes out the other side. Single-asset companies. Asset-centric funds. Project-based financing. Call ...

  Since when did “LP” stand for “Lavish Pharma” – as in, lavishing cash upon the life science venture world? Everyone in our corner of...